HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
26 hedge funds and large institutions have $5.6M invested in Hepion Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
5
Closed
2
Calls
$144K
Puts
–
Net Calls
+$144K
Net Calls Change
+$93K
Top Buyers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$45.7K |
2 |
Renaissance Technologies
New York
|
+$29.6K |
3 |
VF
Virtu Financial
New York
|
+$25.7K |
4 |
UBS Group
Zurich,
Switzerland
|
+$10.9K |
5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$10.8K |